Skip to main content

MUSC News

Read about the education, research and clinical advancements happening across the MUSC academic health system. Discover how our experts are empowering healthy communities, driving innovation and health transformation and reshaping the future workforce for South Carolina and beyond.

Filters


MUSC Health Florence Medical Center.MUSC Health Florence Medical Center emergency department physician, Dr. Bradley Russell, talks to patient Deshantell Canteen about using the new rapid bedside test for heart attack. MUSC Health Florence Medical Center is the first in the state to implement the Abbott’s portable i-STAT 1 instrument.
Health + Heart and Vascular Care
MUSC Health Florence Medical Center adopts faster heart attack detection

When someone arrives in the Emergency Department (ED) with signs of a heart attack, every second matters. Yet confirming whether a heart attack is actually occurring can take precious time. That’s why MUSC Health Florence Medical Center has become the first hospital in South Carolina to use a new test that helps doctors to detect heart attacks faster and more accurately.

“When I came to the emergency room, I was thinking that whatever test was going to be given, it was going to be something very difficult. I thought it was going to be something that was going to hurt. But once it was quickly performed, it was very simple and easy,” said MUSC Health Florence Medical Center patient Deshantell Canteen.

This new test, the Abbott i-STAT High-sensitivity Troponin I Cartridge (hs-TnI), measures very small amounts of cardiac troponin I in the blood. Cardiac troponin is a protein found only in the heart, and elevated levels can signal damage to heart muscle.

Read more arrow_forward

Recent News Releases

More News Releases arrow_forward

Topics

Podcasts

More Podcasts arrow_forward

Events

See More Events arrow_forward

Social

Stories

We wanted to know whether we could detect warning signs of GVHD earlier, before patients feel sick, and soon enough for clinicians to intervene, before the damage becomes irreversible.

Sophie Paczesny, M.D., Ph.D. Co-leader of the Cancer Biology and Immunology Research Program at Hollings Cancer Center

More MUSC news

View news by topic